search
for
 About Bioline  All Journals  Testimonials  Membership  News


Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859 EISSN: 0972-2823
Vol. 53, Num. 4, 2007, pp. 232-235

Journal of Postgraduate Medicine, Vol. 53, No. 4, October-December, 2007, pp. 232-235

Original Article

Retrospective study of severe cases of leptospirosis admitted in the intensive care unit

Division of Critical Care and Emergency Services; Department of Medicine, MOSC Medical College, Kolenchery, Cochin, Kerala
Correspondence Address:Division of Critical Care and Emergency Services; Department of Medicine, MOSC Medical College, Kolenchery, Cochin, Kerala, abyliz@rediffmail.com

Date of Submission: 17-Nov-2006
Date of Decision: 03-Sep-2007
Date of Acceptance: 15-Sep-2007

Code Number: jp07083

Abstract

Objectives: Evaluate patient demographics, risk factors, complications, seropositivity, treatment and outcome among leptospirosis patients.
Design:
Retrospective analysis of 104 patients admitted in the intensive care unit (ICU) with a clinical suspicion of leptopirosis.
Setting:
Ten-bedded medical ICU in a medical school situated in a rural area endemic for leptospirosis.
Main Outcome Measures:
Seropositivity for leptospirosis, patient demographics, risk factors, complications, treatment and survival.
Results:
One hundred and four patients were admitted with a clinical suspicion of leptospirosis. Fifty-three (50.7%) were serologically confirmed cases. Males dominated both groups. Most of the admissions were in the monsoon season. Exposure to moist soil was the main risk factor. The mortality in the seronegative group was 26.8% while it was only 3.8% in the seropositive group. Multi-organ dysfunction syndrome, primarily acute respiratory distress syndrome with thromboctyopenia and renal failure were the causes for mortality. All the patients who died presented late into the illness.
Conclusions:
The initial diagnosis of leptospirosis depends on a high index of clinical suspicion, routinely available diagnostic tests being unreliable in the initial period. A reliable, unsophisticated test should be developed for early detection of this disease. As leptospirosis in its early stage mimics other tropical infections, both medical professionals and the general public (especially with risk of occupational exposure) should be educated about the disease and the need to seek early medical intervention.

Keywords: Acute respiratory distress syndrome, leptospirosis, thrombocytopenia

Leptospirosis is an important zoonotic disease with a worldwide distribution. [1] The disease has a wide spectrum of manifestation varying from mild influenza-like illness to fulminant and often fatal presentation with multi-organ involvement (Weil′s disease). Though advances have taken place in the treatment of leptospirosis, especially involving critical life supports and intensive care unit (ICU) care, the initial diagnosis of leptospirosis still remains presumptive taking into consideration the clinical presentation, risk factors and residence in an endemic area. Tests considered as ′gold-standard′ in the diagnosis of leptospirosis such as serovonversion, rise in antibody titer and leptospiral culture become positive only late into the illness; antibody levels attain detectable levels only by the second week and culture may take two to four weeks. [2] By this period the disease would have taken its course. Hence these tests do not contribute significantly in the initial diagnosis of leptospirosis.

Our hospital is situated in an area endemic for leptospirosis. The economy is predominantly agrarian with rice, pineapple and cash crops like rubber and spices being cultivated. Serologically confirmed cases of leptospirosis were first reported from our institution in 1987-1988 and leptospira was first cultured in 1989. [3] A new serovar has also been identified. [3]

This study was done to evaluate the patient demographics, risk factors, complications, seropositivity, treatment and outcome among patients admitted with a clinical diagnosis of leptospirosis in our ICU.

Materials and Methods

The study was done between 1 st January, 2005 and 30 th June, 2006 (18 months). Patients admitted to the ICU with a clinical diagnosis of leptopirosis were included in the study. The initial diagnosis was based on the clinical scoring system proposed by Faine (WHO guidelines). [4] Patients were also screened for other common tropical infections with similar clinical presentations. Dyspnoea, thrombocytopenia, renal failure, hypotension and myocarditis were the indications for ICU admission. Thrombocytopenia was taken as platelet count of less than 100,000/cu.mm and renal failure was defined as serum creatinine of more than 1.4 mg%. The diagnosis of ARDS/ALI (acute respiratory distress syndrome / acute lung injury) was based on the North American-European Consensus Conference Criteria. [5] The IgM antibody to leptospira was considered positive when the titer was above 80 (tested at admission and after one week if the patient survived). This was based on unpublished data from our hospital, data which supported an earlier study. [3] The patient′s demographic details, month of admission, risk for leptospirosis, leptospira IgM antibody positivity (serologically confirmed cases), complications, treatment details and outcome were reviewed.

All patients received crystalline penicillin which is the standard antibiotic for leptospirosis. [6] Platelets were transfused prophylatically when the platelet count fell below 15,000/cu.mm. Cases of ARDS/ALI received mechanical ventilation (invasive/noninvasive) and methylprednisolone.

Results

One hundred and four patients were admitted with a clinical suspicion of leptospirosis. Fifty-three (50.7%) were serologically confirmed cases; forty-one (39.4 %) were serologically negative (clinically leptospirosis) and 10 (9.6 %) were confirmed to have other diseases.

Males dominated both groups, 40 (75.5%) in the serologically positive group and 40 (75.5%) in the serologically negative group. In both groups the majority of patients were between 20 to 60 years of age.

[Figure - 1] shows that most of the admissions were between June to September. Exposure to soil and water (farming, especially rice) were the main risk factors; laborers in pineapple orchards and rubber tappers were also involved

Increase in liver enzymes, renal failure, thrombocytopenia and ARDS/ALI were the main complications; pancreatitis, myocarditis and pneumonia were also seen [Table - 1]. Fifteen patients received platelet transfusion in both the groups. Nine patients (five in the serologically positive group and four in the serologically negative group) had to be dialyzed .

The mortality in the seronegative group was 26.8% while it was only 3.8% in the seropositive group. The two patients who died in the serologically positive group had ARDS with multi-organ dysfunction syndrome (MODS) - primarily thromboctyopenia and renal failure. In the serologically negative group 11 patients died, six patients of ARDS and five with MODS [Figure - 2]. All the patients who died presented late into the illness.

Discussion

Of the 104 patients admitted with a presumptive diagnosis of leptospirosis, only 50.7% had serological evidence of leptospirosis. This is in agreement with WHO data; the initial diagnosis of leptospirosis still remains clinical, a presumptive one made in the correct epidemiological and clinical context. [4] As there is a clear correlation between complications and delay in onset of treatment [2] it is also imperative that a diagnosis be made early. Also, there is the confounding factor of other tropical infections with similar clinical presentations [2] to be taken care of. In this series 9.6% were confirmed to have other diseases (six were confirmed to have dengue fever, two had hepatitis-A, one was HIV positive and one turned out to be myelofibrosis). Routinely available serological tests such as microscopic agglutination test (MAT) and enzyme-linked immunosorbent assay (ELISA) do not become positive until the second week. In addition, low titers or a delayed response may be observed in severe cases, in immunosuppressed patients and when high doses of antibiotics are administered in the early phase of the disease. [2] For these reasons detection of IgM antibody to leptospirosis may not be reliable. This could also be a plausible explanation for serological negativity and the disproportionate mortality (severity of illness), in this group in this study. Though rapid leptospiral antigen detection tests as PCR (polymerase chain reaction) are available this requires special equipment, dedicated laboratory space and also highly skilled personnel. [2]

Preponderance of male involvement in this study reflects the high risk of occupational exposure in this group. The fact that the majority were in the productive age-group is of concern as often they are the sole bread-winners in the family.

June to September corresponds to the monsoon season when risk for leptospirosis is highest and admissions were also maximum during this time. The risk of leptospirosis among those involved in rice cultivation is well known. We also describe the involvement of pineapple farmers and rubber tappers; abrasions caused by the serrated edges of the pineapple plant and the rubber tapper′s knife may be the portal of entry for the organism.

The classic presentation of leptospirosis is a biphasic illness with complications occurring in the second phase. Important causes of death include renal failure, cardiopulmonary failure and widespread hemorrhage. [2] Leptospirosis with multi-organ involvement uniformly carries a poor prognosis and is more common in patients in whom there has been a delay in the initiation of antibiotics. [2] This was true of all the patients who expired in this study. Also, the benefit of antibiotics after the fifth day of the disease is controversial. [2] The disproportionate mortality, 3.8% in the confirmed group and 26.8% in the negative group probably reflects the severity of illness; a poor antibody response has already been described in those with severe illness. [2]

Many case reports, clinical series and descriptions of outbreaks have documented pulmonary involvement in leptospirosis. [7],[8] Direct involvement of the organism, [9] inflammatory mediators [10] and vasculitis have all been incriminated as the cause. [11],[12] The evidence for use of steroids in ARDS is conflicting [13] but we have observed it to be useful when used in early ARDS due to leptospirosis and have reported it; [14] later studies confirm the same. [15] All the patients with ARDS in the serologically negative group died in this study while only two out of four died in the confirmed group.
Renal involvement is common in leptospirosis. Prognosis in renal failure is usually good unless complicated by multi-organ involvement. [16] All the patients who died of renal failure (one in the serologically positive group and two in the serologically negative group) in this study had multi-organ damage. Bacterial invasion, inflammatory processes, hemodynamic alterations and direct toxicity of bacterial products all contribute to the nephropathy of leptospirosis. [17],[18] Interstitial nephritis is the basic lesion seen. [19]

Unlike renal failure the pathogenesis of thrombocytopenia in leptospirosis is not well elucidated. Postulates include disseminated intravascular coagulation (DIC), [20] toxin-mediated mechanism, [21] as a direct complication of leptospiral vasculitis or due to an undetected platelet antibody. [22] Though thrombocytopenia with widespread hemorrhage is described as one of the complications [2] in leptospirosis, this was not observed in our series.

Increase in liver enzymes - SGPT/ALT and SGOT/AST (up to five times the normal) with a disproportionately high jaundice which was seen in this study has been described as a prognostic marker in leptospirosis. [23] This was the predominant finding in both the groups in this study.

Pancreatitis, [24] myocarditis [25],[26] and pneumonia, [27],[28] the other complications reported in this series are described in leptospirosis.

Conclusion

Leptospirosis is a zoonotic disease with multi-system involvement in severe cases. Advances in critical care life supports may have improved the prognosis of this disease but the initial diagnosis still depends on a high index of clinical suspicion, routinely available diagnostic tests being unreliable in the initial period. Development of a reliable, unsophisticated diagnostic technique for early detection would mitigate this problem.

As leptospirosis in its early stage mimics other tropical infections of less severity, there is a need to educate both medical professionals and the general public (especially with risk of occupational exposure) about the disease and the need to seek early medical intervention.

The pathogenesis and treatment of complications of leptospirosis like renal failure, thrombocytopenia and ARDS, especially the role of steroids merits further evaluation.

Acknowledgment

The authors wish to acknowledge the help given by Dr. Marina Rajan Joseph, Associate Professor and Mrs. Celine T.M, Assistant Professor, of Department of Community Medicine, M.O.S.C Medical College.

References

1.Bharti AR, Nally JE, Ricalde JN, Matthias MA, Diaz MM, Lovett MA, et al . Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.  Back to cited text no. 1    
2.Terpstra WJ. International leptospirosis Society. Human Leptospirosis: Guidance for diagnosis, surveillance and control. World Health Organization: Geneva; 2003.  Back to cited text no. 2    
3.Kuriakose M, Eapen CK, Paul R. Leptospirosis in Kolenchery, Kerala, India: Epidemiology, prevalent local serogroups and serovars and a new serovar. Eur J Epidemiol 1997;13:691-7.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Faine S. Guidelines for the control of Leptospirosis. World Health Organization: Geneva; 1982. WHO offset publication No. 67.  Back to cited text no. 4    
5.Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al . The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.  Back to cited text no. 5    
6.Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, et al . Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-5.  Back to cited text no. 6  [PUBMED]  
7.O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991;13:705-9.  Back to cited text no. 7  [PUBMED]  
8.Martinez Garcia MA, de Diego Damia A, Menendez Villanueva R, López Hontagas JL. Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 2000;19:471-4.  Back to cited text no. 8    
9.Silva JJ, Dalston MO, Carvalho JE, Setubal S, Oliveira JM, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002;35:395-9.  Back to cited text no. 9    
10.Nally JE, Chantranuwat C, Wu XY, Fishbein MC, Pereira MM, Da Silva JJ, et al . Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004;164:1115-27.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]
11.Miller NG, Allen JE, Wilson RB. The pathogenesis of hemorrhage in the lung of the hamster during acute leptospirosis. Med Microbiol Immunol 1974;160:269-78.  Back to cited text no. 11  [PUBMED]  
12.De Brito T, Bohm GM, Yasuda PH. Vascular damage in acute experimental leptospirosis of the guinea-pig. J Pathol 1979;128:177-82.  Back to cited text no. 12    
13.Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, et al . Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-84.  Back to cited text no. 13  [PUBMED]  [FULLTEXT]
14.Ittyachen AM, Lakshmanakumar VK, Eapen CK, Joseph MR. Methylprednisolone as adjuvant in treatment of acute respiratory distress syndrome owing to leptospirosis: A pilot study. Indian J Crit Care Med 2005;9:133-6.  Back to cited text no. 14    
15.Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: An excellent response to bolus methylprednisolone. Postgrad Med J 2006;82:602-6.  Back to cited text no. 15  [PUBMED]  [FULLTEXT]
16.Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 1999;61:630-4.  Back to cited text no. 16  [PUBMED]  [FULLTEXT]
17.Sitprija V, Losuwanrak K, Kanjanabuch T. Leptospiral nephropathy. Semin Nephrol 2003;23:42-8.  Back to cited text no. 17    
18.Sitprija V. Overview of tropical nephrology. Semin Nephrol 2003;23:3-11.  Back to cited text no. 18  [PUBMED]  [FULLTEXT]
19.Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med 2005;51:184-8.  Back to cited text no. 19    
20.Sitprija V, Papatanagul V, Mertowidjojo K, Boonpcknavig V, Boonpcknavig S. Pathogenesis of renal disease in leptospirosis: Clinical and experimental studies. Kidney Int 1980;17:827-36.  Back to cited text no. 20    
21.O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis 1991;13:705-9.  Back to cited text no. 21  [PUBMED]  
22.Kahn JB. A case of Weil's disease requiring steroid therapy for thrombocytopenia and bleeding. Am J Trop Med Hyg 1982;31:1213-5.  Back to cited text no. 22  [PUBMED]  [FULLTEXT]
23.Chang ML, Yang CW, Chen JC, Ho YP, Pan MJ, Lin CH, et al . Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis. World J Gastroenterol 2005;11:5553-6.  Back to cited text no. 23  [PUBMED]  [FULLTEXT]
24.Edwards CN, Evarard CO. Hyperamylasemia and pancreatitis in leptospirosis. Am J Gastroenterol 1991;86:1665-8.  Back to cited text no. 24  [PUBMED]  
25.Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Leptospirosis in Barbados: A clinical study. West Indian Med J 1990;39:27-34.  Back to cited text no. 25  [PUBMED]  
26.de Brito T, Morais CF, Yasuda PH, Lancellotti CP, Hoshino-Shimizu S, Yamashiro E, et al . Cardiovascular involvement in human and experimental leptospirosis: Pathologic findings and immunohistochemical detection of leptospiral antigen. Ann Trop Med Parasitol 1987;81:207-14.  Back to cited text no. 26    
27.Teglia OF, Battagliotti C, Villavicencio RL, Cunha BA. Leptospiral pneumonia. Chest 1995;108:874-5.  Back to cited text no. 27  [PUBMED]  [FULLTEXT]
28.Hill MK, Sanders CV. Leptospiral pneumonia. Semin Respir Infect 1997;12:44-9.  Back to cited text no. 28  [PUBMED]  

Copyright 2007 - Journal of Postgraduate Medicine


The following images related to this document are available:

Photo images

[jp07083t1.jpg] [jp07083f2.jpg] [jp07083f1.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil